Finally, in patients suffering from severe depression, the administration of a MAOA/MAOB inhibitor along with an oral supplementation with L-phenylalanine was reported to exert beneficial effects via a mechanism presumably involving an increase in brain β-PEA levels [54]. The gene discussed is MAOA; the disease is depressive disorder.